Biomedical Engineering Reference
In-Depth Information
[35]
Davis ME, Z Chen and DM Shin (2008). Nanoparticle therapeutics: an emerging treatment
modality for cancer. Nature Reviews Drug Discovery 7: 771-782.
[36]
Senzer N, J Nemunaitis, D Nemunaitis, C Bedell, G Edelman, M Barve, R Nunan, KF Pirollo,
A Rait and EH Chang (2013). Phase I study of a systemically delivered p53 nanoparticle in
advanced solid tumors. Molecular Therapy 21: 1096-1103.
[37]
Meyer K, P Rajanahalli, M Ahamed, JJ Rowe and Y Hong (2011). ZnO nanoparticles induce
apoptosis in human dermal fibroblasts via p53 and p38 pathways. Toxicology in Vitro 25:
1721-1726.
[38]
Wu J, J Sun and Y Xue (2010). Involvement of JNK and P53 activation in G2/M cell cycle arrest
and apoptosis induced by titanium dioxide nanoparticles in neuron cells. Toxicology Letters
199: 269-276.
[39]
Ahamed M, MJ Akhtar, MA Siddiqui, J Ahmad, J Musarrat, AA Al-Khedhairy, MS AlSalhi
and SA Alrokayan (2011). Oxidative stress mediated apoptosis induced by nickel ferrite
nanoparticles in cultured A549 cells. Toxicology 283: 101-108.
[40]
Ahamed M, R Posgai, TJ Gorey, M Nielsen, SM Hussain and JJ Rowe (2010). Silver nanoparti-
cles induced heat shock protein 70, oxidative stress and apoptosis in Drosophila melanogaster.
Toxicology and Applied Pharmacology 242: 263-269.
[41]
Huang Y, L He, W Liu, C Fan, W Zheng, Y-S Wong and T Chen (2013). Selective cellular
uptake and induction of apoptosis of cancer-targeted selenium nanoparticles. Biomaterials 34:
7106-7016.
[42]
Downward J (1998). Ras signalling and apoptosis. Current Opinion in Genetics and Development
8: 49-54.
[43]
Wang G, Z Nikolovska-Coleska, C-Y Yang, R Wang, G Tang, J Guo, S Shangary, S Qiu,
W Gao and D Yang (2006). Structure-based design of potent small-molecule inhibitors of anti-
apoptotic Bcl-2 proteins. Journal of Medicinal Chemistry 49: 6139-6142.
[44]
Liu X and J Sun (2010). Endothelial cells dysfunction induced by silica nanoparticles through
oxidative stress via JNK/P53 and NF-kappaB pathways. Biomaterials 31: 8198-8209.
[45]
Bisht S and A Maitra (2009). Dextran-doxorubicin/chitosan nanoparticles for solid tumor
therapy. Wiley Interdisciplinary Reviews in Nanomedicine and Nanobiotechnology 1:
415-425.
[46]
Chen Y, JJ Wu and L Huang (2010). Nanoparticles targeted with NGR motif deliver c-myc
siRNA and doxorubicin for anticancer therapy. Molecular Therapy 18: 828-834.
[47]
Dobrovolskaia MA and SE McNeil (2007). Immunological properties of engineered nanomate-
rials. Nature Nanotechnology 2: 469-478.
[48]
Xiang SD, A Scholzen, G Minigo, C David, V Apostolopoulos, PL Mottram and M Plebanski
(2006). Pathogen recognition and development of particulate vaccines: does size matter?
Methods 40: 1-9.
[49]
Val S, S Hussain, S Boland, R Hamel, A Baeza-Squiban and F Marano (2009). Carbon black
and titanium dioxide nanoparticles induce pro-inflammatory responses in bronchial epithelial
cells: need for multiparametric evaluation due to adsorption artifacts. Inhalation Toxicology 21
(Suppl 1): 115-122.
[50]
Kagan VE, NV Konduru, W Feng, BL Allen, J Conroy, Y Volkov, II Vlasova, NA Belikova,
N Yanamala, A Kapralov,
et al
. (2010). Carbon nanotubes degraded by neutrophil myeloper-
oxidase induce less pulmonary inflammation. Nature Nanotechnology 5: 354-359.
[51]
Lamprecht A, N Ubrich, H Yamamoto, U Schäfer, H Takeuchi, P Maincent, Y Kawashima and
C-M Lehr (2001). Biodegradable nanoparticles for targeted drug delivery in treatment of
inflammatory bowel disease. Journal of Pharmacology and Experimental Therapeutics 299:
775-781.
[52]
Howard KA, SR Paludan, MA Behlke, F Besenbacher, B Deleuran and Jr Kjems (2008).
Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for
anti-inflammatory treatment in a murine arthritis model. Molecular Therapy 17: 162-168.
[53]
Dobrovolskaia MA, P Aggarwal, JB Hall and SE McNeil (2008). Preclinical studies to under-
stand nanoparticle interaction with the immune system and its potential effects on nanoparticle
biodistribution. Molecular Pharmaceutics 5: 487-495.
